KOSDAQ · Healthcare · ₩272B
₩2,875+0.88%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.8% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“매출보다 신약 연구 성과가 다음 성장을 이끌어요.”
In the company's words · 2026 2분기 filing